-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Revolution Medicines, Maintains $195 Price Target

Benzinga·07/06/2026 13:45:54
Listen to the news
HC Wainwright & Co. analyst Robert Burns reiterates Revolution Medicines (NASDAQ:RVMD) with a Buy and maintains $195 price target.